The transaction is a natural continuation of the consolidation in the life insurance sector in recent years, and the rationale behind is to create a focused non-life insurance company, to improve the combined ratio and the quality of earnings by divesting the illness and accident business, as well as to free significant tied-up capital and thus increase the dividend capacity considerably. After closing of the transaction, Topdanmark Forsikring A/S will continue to distribute life insurance products for Topdanmark Livsforsikring A/S and Nordea, which will strengthen the existing partnership between Nordea and Topdanmark on non-life insurance products. Closing of the transaction is, among other things, subject to relevant regulatory approvals. At present, the divestment is expected to be completed in the second half of 2022. In consequence of the divestment, Topdanmark A/S expects to pay transaction costs as well as costs for unwinding and restructuring of approx. DKK 0.3bn in total.